Showing results (801-810 of 1,383) with videos related to

Sort By:
Pageof 139
ACS Pharmacology & Translational Science|April 16, 2026
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant HypertensionImma Capriello, Alexander Dömling
ACS Pharmacology & Translational Science|May 14, 2026
Roles of RNA-Binding Nuclear Proteins in Alzheimer's Disease PathophysiologySandeep Kumar, Arun Upadhyay
ACS Pharmacology & Translational Science|May 14, 2026
A Trypanothione Synthetase-Based Subunit Vaccine Induces Protective Th1 Immunity against Visceral Leishmaniasis in MiceEhasanullah Khan, Atreyee Chatterjee, Shiv Kumar, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures"Antonia C Darragh, Andrew M Hanna, Justin Lipner, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Polyphenol Antioxidants Inhibit Peroxynitrite-Mediated DNA Damage In Vitro and in E. coliHsiao C Wang, Nathan R Perron, Fatema Tuz Zohara, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological TargetsMuhammad Rafehi, Franziska Tägl, Nike Sophia Arlt, et al.
ACS Pharmacology & Translational Science|February 19, 2026
When Neutrophils Go Rogue: Dysregulated Inflammation in Airway Diseases and Implications for TherapyYimin Zhu, Sarmi Sardar, Jane E Bourke, et al.
ACS Pharmacology & Translational Science|February 19, 2026
SCaN: A Screening and Characterization Platform for Nanosuspensions Enables In Vivo Delivery of a Crystalline hRpn13Pru DegraderChristine S Brugger-Muli, Snehal M Gaikwad, Wendy du Bois, et al.
ACS Pharmacology & Translational Science|February 19, 2019
Novel and Potent Dopamine D2 Receptor Go-Protein Biased AgonistsAlessandro Bonifazi, Hideaki Yano, Adrian M Guerrero, et al.
ACS Pharmacology & Translational Science|April 17, 2020
Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying ProteinsYi-Lynn Liang, Matthew J Belousoff, Madeleine M Fletcher, et al.
Pageof 139